The peak age ranges for pregnancy and inflammatory bowel disease (IBD) coincide, and many women develop IBD during their reproductive years. This contribution reviews the major studies on the subject, and is sub-divided into two broad considerations: the effects of the disease on fertility, pregnancy and other factors related to the puerperium, and, conversely, the effects of pregnancy and childbirth on the disease: its natural history and recent surgical treatment options, namely pouch anatomy and function. A systematic review of the literature from 1950 to the present was undertaken using Medline and the keywords inflammatory bowel disease and pregnancy.
Introduction
Several large studies have addressed the interaction between inflammatory bowel disease (IBD) and pregnancy, but these have suffered from a number of methodological limitations. Firstly, many of the classic studies [1, 2, 3] were conducted in the 1950s, before the modern era of drug therapy. Furthermore patients who were treated with corticosteroids during that period were not clearly separated from those who were not, and the drug therapy of patients was inconsistent. Secondly, there was no patient stratification. Thus no distinction was made between different anatomical parts affected, or type of treatment and presence and types of complications in either disease. Thirdly, no controlled trials of therapy have been carried out during pregnancy, and therefore conclusions can be made only tentatively on the basis of case material.
Effect of IBD on pregnancy

Fertility and pregnancy
Crohn's disease
Opinion regarding fertility in women with Crohn's disease (CD) has been divided. In one of the earliest large studies Crohn et al. [3] concluded that fertility is not impaired by CD. However, Fielding and Cooke [4] came to precisely the opposite conclusion. Fertility has since been shown to be decreased in CD in several studies. De Dombal et al. [5] found that only 40 of 86 women studied became pregnant during their survey (i.e. a subfertility rate of 53.5%); it also appeared, however, that after surgery these patients became pregnant almost as often as other women in the population at large. The question therefore arose as to whether this reduced gravidity was voluntary or disease related. The only previous report that attempted to address this question was a case-control design which reported reduced fertility in women, but the methods of measuring fertility in this study were highly criticised [6] .
In a large European case-control study, Mayberry et al. [7] found that the reduced fertility rate in CD patients is not voluntary since contraception is used less in CD patients than in controls. Aetiological factors included ovary and tube disruption by the inflammatory process (especially on the right side); perirectal, perineal and rectovaginal abscesses and fistulas resulting in dyspareunia and decreased libido; overall toxicity from CD (fever, abdominal pain, malnutrition); and reduced fertility in men taking sulfasalazine. Subsequent work by Baird et al. [8] suggested that reduced fertility is due to patients' choice and is not disease related.
Ulcerative colitis
In ulcerative colitis (UC) several studies have shown that the infertility rate among women is probably no greater than that of the general population [9, 10, 11] . However, female fertility is probably impaired by surgical treatment, particularly after rectal excision or if pelvic sepsis has complicated surgical treatment. Male infertility is influenced mostly by sulphasalazine and rectal excision (see later).
Effect of Crohn's disease on pregnancy
Many of the older studies suggested that the occurrence of IBD and pregnancy in the same patient carries an extremely unfavourable prognosis [12, 13] . Subsequent studies on the subject, however, found no effect of the disease on either the mother or the child. Since then an increasing number of studies have been reported with mixed results. Several studies over the past three decades have been consistent in concluding that neither CD nor UC has any unfavourable effect on the outcome of pregnancy [2, 14, 15] . The incidence of premature births, spontaneous abortions, stillbirths and congenital abnormalities were similar to the figures in the general population. Summarising these and other studies, Miller [9] reviewed the outcome of 748 women with CD from ten major series and concluded that the chances of having a normal infant were similar to the normal population: less than 1% had congenital abnormalities and only 12% had a spontaneous abortion or stillbirth.
On the other hand, other workers have shown a significantly higher rate of abnormalities such as small babies (7%), premature labour (6%) and respiratory distress (1%), concluding that patients with active disease at the time of conception have a higher incidence of abnormal pregnancies than in the normal population [16] . Donaldson et al. [17] have shown that the presence of active IBD at the time of conception doubles the chance of spontaneous abortion. Similarly, the rate of foetal complications has been reported as being higher in patients with active disease [14] . In a study by Baiocco et al. [18] pregnant women with active CD were found to 217 have an increased risk of complications including developmental defects, stillbirths and spontaneous abortions. In a case-controlled study of late pregnancy outcome, Fedorkow et al. [19] found a significantly higher preterm delivery rate in patients with IBD than in the control group, especially when exacerbation of the bowel disease occurred during pregnancy. These findings have been reproduced by Baird et al. [8] who found a significantly higher risk of preterm birth in women with both CD and UC. In a large Danish study of pregnancy and CD encompassing a 13-year period and 109 pregnancies in 68 women with CD, Nielsen et al. [20] found a frequency of induced abortion of 17.4%, far exceeding the average rate of 2.7% of other studies, and a premature delivery frequency of 13.8%, compared to 3.3% in the rest of the literature, but similar rates of spontaneous abortion and stillbirths. The increased induced abortion rate was thought to result mostly from a Danish law which allows women to undergo voluntary abortion. Women who had resection surgery during their pregnancy were at increased risk of premature delivery.
Influence of ulcerative colitis on pregnancy
Several of the earlier studies had shown that pregnancy is largely unaffected by UC, and this has been confirmed by more recent studies. Various reports including more than 1000 pregnant patients in total [3, 14, 20, 21, 22, 23, 24] have shown normal healthy offspring in 76-97%, congenital abnormalities in 0-3%, and an average rate of 8.6% spontaneous abortions and 2.9% induced abortions, approximating the incidence in a healthy population. Closer scrutiny of published studies show that if the outcome is analysed irrespective of the severity of colitis, the incidence of abortion, congenital anomaly and stillbirth is actually lower in colitics than in the general population, with average figures of normal live births of 86%, spontaneous abortion of 7% and stillbirth incidence of 2%, which compares favourably with those of the normal population.
Drug therapy for IBD and its effect on pregnancy
The safety of dug therapy is the foremost consideration in pregnant women with IBD. This has caused considerable conflict between obstetricians who recommend stopping all drugs during pregnancy, and gastroenterologists who maintain that most of these drugs are safe during pregnancy.
Sulfasalazine
Sulphasalazine and its 5-acetylsalicylic acid (5-ASA) derivative cross the placental barrier and are secreted into breast milk. However, maternal milk and serum 5-ASA levels are very low because of poor absorption. Apart from the known side effects of the sulphapyridine moiety, kernicterus caused by the displacement of unconjugated bilirubin by binding of the sulphapyridine moiety to albumin is a theoretical risk.
In practice, neonatal jaundice is rare, probably because sulphasalazine is poorly absorbed from the small bowel [25] . Long-term therapy with sulfasalazine has not been associated with complications such as pre-maturity, low birth weight and spontaneous abortion but does interfere with folate absorption. Sulfasalazine may have teratogenic effects in animals, and several reports have described congenital malformations after sulfasalazine exposure [26, 27, 28, 29] . Maintenance sulfasalazine should be continued in pregnant patients since the risks to the foetus are greater if relapse occurs than from the drug itself.
5-ASA rarely causes toxicity, compared to its parent drug sulfasalazine, and various preparations which do not contain the sulfapyridine moiety are now used. A prospective controlled cohort study from Toronto, Canada, suggested that mesalamine does not represent a major teratogenic risk in humans when used in the recommended doses [30] . Rare complications have been reported, including skin eruptions, interstitial nephritis and thrombocytopenia but are no more common than in nonpregnant women and entirely reversible.
Corticosteroids
Corticosteroids cross the placenta but are rapidly converted to the less active cortisone and prednisolone; foetal hypothalamic-pituitary-adrenal suppression is rare as levels in the foetal circulation are only 10-20%. Although steroids have been implicated as a cause of congenital abnormality, there is no evidence that foetal damage is increased among women taking steroids [31] , although there may be an increased incidence of foetal distress, placental insufficiency and stillbirth [32, 33] . In the Oxford series the percentage of live births was significantly lower in the group of women taking topical and systemic steroids than in the other groups, and in a study of 531 pregnancies associated with IBD, Mogadam et al. [34] found no evidence for an increased incidence of congenital abnormality or stillbirths among women requiring steroids during pregnancy. Prednisolone concentrations in milk are low [35] . Hence medication in pregnancy and the puerperium is relatively safe. The small potential foetal risk from temporary use of large doses must be weighed against the greater foetal risk from severe CD activity and from the alternative of surgical intervention.
Immunosuppressives
Immunosuppressive therapy with either azathioprine or 6-mercaptopurine (6-MP) has an established role in the treatment of refractory CD and UC [36] . Their safety in pregnancy, however, remains questionable; animal models have shown low birth weight, congenital abnormalities and small litter size. In a series of over 500 pregnant renal transplant patients, however, azathioprine was found to be relatively safe; in those where birth anomalies occurred a higher dose than is used in IBD had been used to prevent renal allograft rejection [37] . In a small retrospective study of 16 pregnant women on azathioprine therapy no resultant congenital abnormalities were found, and all offspring have been found to be well with a follow-up of up to 16 years after birth [38] .
In a study looking at the outcome of pregnancies when fathers had been treated with 6-MP within 3 months of conception, compared with fathers who had not been on 6-MP, it was found that the risk of complications (including spontaneous abortions) was significantly greater in the former group [39] . Experience with pregnant transplant patients on cyclosporin has shown a high incidence of prematurity and low birth weight [40] ; in addition, the drug may not be used in pregnancy because of nephrotoxicity, hypertension and hepatotoxicity. Methotrexate is contraindicated during pregnancy because of a high incidence of mutagenicity and teratogenicity [41] . Metronidazole is often used as an effective agent for perirectal abscesses and fistulas in CD. In animals, it crosses the placenta and is teratogenic and tumorigenic in high doses, and causes pulmonary, hepatic and mammary tumours in rodents. This has raised concern about its use in humans during pregnancy, despite the absence of controlled therapeutic trials. However, a study of 206 pregnant women treated during the first trimester has revealed no association with congenital malformations or spontaneous abortions [42] .
Effect of pregnancy on the course of IBD
In general it is said that quiescence of disease before conception is likely to be followed by quiescence during pregnancy. Also, most changes in the state of colitis, whether improvement or exacerbation, occur during the first trimester [20] . It is not possible, however, to predict the course of IBD during subsequent pregnancies, as several workers have found that colitis can behave quite differently from one pregnancy to the other.
Effect of pregnancy on the course of ulcerative colitis
Most workers have grouped their patients according to whether the colitis is active or inactive at the onset of pregnancy, and have shown that in general the course of IBD during pregnancy is directly affected by disease activity before conception. In a series of 324 patients Mogadam et al. [43] found that 75% of those with quiescent to mild disease remained so, while 51% of patients with active IBD continued to have moderate to severe disease. De Dombal et al. [22] have suggested that a rise in serum cortisol during late pregnancy and a precipitous fall postpartum accounted for the fall and rise in the relapse rate in UC.
Chronic disease in remission
Several studies have shown a relapse rate varying from 10% to 54% [1, 3, 21, 22] . From these and other reports it may be concluded that the course of UC during pregnancy is correlated with disease activity at the time of conception and is no greater than the relapse rate in a comparable group of non-pregnant women [20] . Several studies have shown that two-thirds of those in whom UC was inactive at conception continue to have inactive disease throughout pregnancy [21] .
Active disease during conception
Most of those with active disease at conception usually continue to have active disease during pregnancy, and proportions varying between 25 and 100% in various studies have been found to experience a deterioration in their symptoms unless drug therapy was initiated or used more vigorously [2, 3, 21, 43] . It was previously also thought that there is an increased risk of relapse in the puerperium because of a fall in endogenous corticosteroid levels, but this does not seem to be true in practice [3, 14] .
First attack during pregnancy
Experiencing the first disease attack during pregnancy is relatively uncommon, but patients who do so constitute the most worrying. There has been general agreement that when UC first appears in either pregnancy or the puerperium it is apt to be extremely severe and is always more lethal than relapses. In the series of Abramson et al. [1] , which predates the use of steroids in treatment, four of five such patients died from fulminating colitis soon after delivery or spontaneous abortion, and two deaths out of five were reported in the series of Banks et al. [2] . In MacDougall's [21] series 12 of 26 cases (46%) were very severe, and there were two fatal cases. This group of patients now have a better outlook as a result of better understanding and earlier management of the disease and more vigorous management. Three cases have 219 been reported requiring surgery during pregnancy which was achieved without detriment to the mother or foetus [44, 45] . Similarly, four cases have been reported of severe colitis at term requiring emergency colectomy, three for toxic dilatation; there was no maternal mortality, but two of the four infants died [46] . A first attack of colitis in the puerperium is also relatively rare, only 9 out of 209 developing it in the Willoughby and Truelove [14] series, all having mild disease.
Pregnancy after colectomy and ileal pouch function following childbirth
Pregnancy in women who have had restorative proctocolectomy is usually uncomplicated, but a review of the literature suggest that there is a higher rate of caesarian section than after conventional proctocolectomy because of the fear of compromising continence [2, 22, 47, 48] . In a review of 43 women who had a successful pregnancy and delivery following ileal pouch anal anastomosis (IPAA) Juhasz et al. [49] found that pregnancy is generally well tolerated, with relatively normal pregnancies and healthy babies at term. Pouch-related complications occurred in 7% of patients but surgery was not required in any. These results compared favourably with complication rates reported for pregnant patients with stomas (29%) or Kock pouches (53%) [50, 51] . It is likely that the higher complication rate in the stoma patients is related to the direct effects of abdominal wall distension on the ileostomy and Kock pouch.
The pelvic location of the pouch protects it from the effects of abdominal wall distension but makes it more susceptible to pressure exerted on the pelvic floor during pregnancy and delivery. In a small retrospective study, Scott et al. [52] also found that pregnancy is safe in women with an IPAA and suggested that indications for caesarian section should only be obstetric. From the functional point of view, IPAA patients have been found in some studies [49] to experience increased daytime and night time stool frequency and incontinence, but not in others [52, 53] . These changes are the result both of decreased reservoir capacity of the pouch from an enlarged uterus, but also from indirect effects of the pregnant uterus, such as effects on the pudendal nerve.
With regard to mode of delivery, several studies have shown no relationship between length of labour, increased birth weights, and multiple pregnancies and adverse pouch outcome [49] , although caesarian section rate has been found to be higher among IPAA patients (44%) than among ostomy patients (37%) [50] or patients with Kock pouches (24%) [51] . However, fewer than 50% of these caesarian deliveries were performed for obstetric reasons, indicating that this increased rate may be in part because of uncertainty about how these patients would fare with vaginal deliveries.
Effect of pregnancy on the course of CD The course of CD during pregnancy is similar to that of UC in that quiescence of disease before conception is likely to be followed by quiescence during pregnancy, and vice versa. De Dombal et al. showed that patients with CD did not face any major additional gastrointestinal risk during pregnancy [5] ; indeed the symptoms were more likely to improve during pregnancy than to relapse. Conversely a relapse of symptoms after delivery was found in 40% of women. This paralleled the findings obtained earlier by the authors for UC [22] and agreed with the trend indicated by Fielding et al. [4] .
Chronic disease in remission
Relapse rates in this group of patients is reported to vary from 9% to 39% [9, 53, 54] . In these studies relapse was found to be most common in the first trimester and the puerperium.
Active disease
Studies show a wide range of percentage of patients who improve, remain static or worsen. Thus Crohn et al. [3] showed that 13% worsened, whereas 47% worsened in the Nielsen et al. series [20] . Taking other studies into account, it may be said that on average about one-third of patients go into remission, and that in one-third the disease worsens.
First attack during pregnancy
There are few data on patients suffering their attack during pregnancy, but it is usually thought that the prognosis is generally poor. Martimbeau et al. [55] reported two cases of CD presenting in pregnancy and found eight other cases in the literature to 1974. Eight of the 10 mothers required surgery and 6 of the 11 infants died. Since that time there have been a few more reported cases of CD presenting in pregnancy with no perinatal or maternal deaths, suggesting improved medical and surgical therapy [44, 45, 46, 56] .
Effect of vaginal delivery and episiotomy
There has been little work looking specifically at this problem, but a study by Brandt et al. [57] of 117 women showed a 17.9% rate of development of perineal disease per vaginal delivery in those without pre-existing perineal disease within 2 months of delivery, compared to published rates of 0.5-3.0% in the normal population. Al-220 though admitting that data generated from such a survey is necessarily biased, the question of optimal obstetric management of the perineum in these patients remains unanswered.
Management of IBD during pregnancy
There is no contraindication to sigmoidoscopy or endoscopic biopsy if indicated during pregnancy; there are limited data on the safety of colonoscopy during pregnancy, but the procedure should be avoided if possible [58] . Radiological examinations should be avoided whenever possible because of radiation teratogenicity except for plain films to confirm the diagnosis of toxic megacolon or intestinal obstruction. A review by Mole [59] concluded that the overall risk of serious harm (mainly cancer) to the foetus or embryo from diagnostic X-rays in the first trimester of pregnancy is probably at most only one case per 1000 for each 1 cGy tissue dose received. In the pregnant woman a single plain abdominal radiograph need only involve a tissue dose of less than 0.2 cGy to the foetus [60] , and further protection from the primary radiation beam could be provided by shielding of the lower abdomen. It is therefore suggested that the risk to the foetus should not unduly weigh against the desirability of abdominal radiography in the pregnant patient. Studies have demonstrated that exposure to 24 cGy or less in the prenatal period is not associated with birth defects or cancer in the first years after birth [61] , although radiography is probably safer during the third trimester than during the first or second trimester. Computed tomography should equally only be used when absolutely necessary to aid in the diagnosis or recognition of complications of CD.
Surgical intervention for UC during pregnancy is appropriate for unequivocal indications including megacolon, perforation and bleeding. Subtotal colectomy with ileostomy is associated with a 60% risk of postoperative abortion. In a study by Anderson et al. [46] two of four infants died in four patients undergoing emergency colectomy, but there were no maternal deaths. There have been over 30 such cases in the literature [44, 45, 62] . The overall foetal mortality rate among these patients has been 53% and maternal mortality rate 29%, the high stillbirth rate probably reflecting the severity of the disease rather than the effects of operation. Pertinent technical points include bringing the bowel out through an extraperitoneal plane deep to the broad ligaments and placing the ileostomy rather high on the abdominal wall as it may sink to a lower level following pregnancy.
